<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns="http://publications.europa.eu/TED_schema/Export" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://publications.europa.eu/TED_schema/Export TED_EXPORT.xsd" DOC_ID="025133-2011" EDITION="2011016"><TECHNICAL_SECTION><RECEPTION_ID>11-017333-016</RECEPTION_ID><DELETION_DATE>20110228</DELETION_DATE><FORM_LG_LIST>EN </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS><OLD_HEADING>2220</OLD_HEADING></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:title="TED WEBSITE" xlink:href="http://ted.europa.eu" xlink:type="simple"></XML_SCHEMA_DEFINITION_LINK><OFFICIAL_FORMS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"></OFFICIAL_FORMS_LINK><FORMS_LABELS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"></FORMS_LABELS_LINK><ORIGINAL_CPV_LINK xlink:href="http://ted.europa.eu" xlink:type="simple "></ORIGINAL_CPV_LINK><ORIGINAL_NUTS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"></ORIGINAL_NUTS_LINK></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>16</NO_OJ><DATE_PUB>20110125</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2011/S 16-025133</NO_DOC_OJS><URI_LIST><URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:025133-2011:TEXT:EN:HTML</URI_DOC></URI_LIST><LG_ORIG>EN</LG_ORIG><ISO_COUNTRY VALUE="UK"></ISO_COUNTRY><IA_URL_GENERAL>https://nhsbt.bravosolution.co.uk</IA_URL_GENERAL><ORIGINAL_CPV CODE="85121200">medical specialist services</ORIGINAL_CPV><ORIGINAL_CPV CODE="85100000">health services</ORIGINAL_CPV><ORIGINAL_CPV CODE="85141000">services provided by medical personnel</ORIGINAL_CPV><VALUES_LIST></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20110120</DS_DATE_DISPATCH><DT_DATE_FOR_SUBMISSION>20110228 12:00</DT_DATE_FOR_SUBMISSION><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="4">Service contract</NC_CONTRACT_NATURE><PR_PROC CODE="2">Restricted procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="3">Submission for one or more lots</TY_TYPE_BID><AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><MA_MAIN_ACTIVITIES CODE="O">Other</MA_MAIN_ACTIVITIES><HEADING>01322</HEADING></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>UK</TI_CY><TI_TOWN>Бристол</TI_TOWN><TI_TEXT>Консултации и лечение от лекари специалисти</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Služby odborných lékařů</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Konsultation og behandling hos medicinske specialister</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Dienstleistungen von Fachärzten</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Eriarsti teenused</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>UK</TI_CY><TI_TOWN>Μπρίστολ</TI_TOWN><TI_TEXT>Ιατρικές υπηρεσίες παρεχόμενες από ειδικευμένους γιατρούς</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>medical specialist services</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Servicios de médicos especialistas</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Services prestés par les médecins spécialistes</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Servizi medici specialistici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>UK</TI_CY><TI_TOWN>Bristole</TI_TOWN><TI_TEXT>Medicīnas speciālistu pakalpojumi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>UK</TI_CY><TI_TOWN>Bristolis</TI_TOWN><TI_TEXT>Gydytojų specialistų paslaugos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>UK</TI_CY><TI_TOWN>Briostó</TI_TOWN><TI_TEXT>Medical specialist services</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Orvosi szakszolgáltatás</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Servizzi mediċi speċjalizzati</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Diensten door medische specialisten</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Specjalistyczne usługi medyczne</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Serviços de medicina especializada</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Servicii prestate de medici specialişti</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Služby lekárov-špecialistov</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Storitve zdravnikov specialistov</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Erikoislääkäripalvelut</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>UK</TI_CY><TI_TOWN>Bristol</TI_TOWN><TI_TEXT>Medicinska specialisttjänster</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="EN">NHS Blood &amp; Transplant</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT CATEGORY="ORIGINAL" LG="EN" VERSION="R2.0.7.S03.E01" FORM="2"><FD_CONTRACT CTYPE="SERVICES"><CONTRACTING_AUTHORITY_INFORMATION><NAME_ADDRESSES_CONTACT_CONTRACT><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION>NHS Blood &amp; Transplant</ORGANISATION><ADDRESS>North Bristol Park, Filton</ADDRESS><TOWN>Bristol</TOWN><POSTAL_CODE>BS34 7QH</POSTAL_CODE><COUNTRY VALUE="UK"></COUNTRY><CONTACT_POINT>Please refer to Section III.2.1 on how to register as a supplier and Express an Interest</CONTACT_POINT></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT><URL_GENERAL>https://nhsbt.bravosolution.co.uk</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT><FURTHER_INFORMATION><IDEM></IDEM></FURTHER_INFORMATION><SPECIFICATIONS_AND_ADDITIONAL_DOCUMENTS><IDEM></IDEM></SPECIFICATIONS_AND_ADDITIONAL_DOCUMENTS><TENDERS_REQUESTS_APPLICATIONS_MUST_BE_SENT_TO><IDEM></IDEM></TENDERS_REQUESTS_APPLICATIONS_MUST_BE_SENT_TO></NAME_ADDRESSES_CONTACT_CONTRACT><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY_OTHER VALUE="OTHER">Special Health Authority</TYPE_OF_CONTRACTING_AUTHORITY_OTHER><TYPE_OF_ACTIVITY VALUE="HEALTH"></TYPE_OF_ACTIVITY><TYPE_OF_ACTIVITY_OTHER VALUE="OTHER">Special Health Authority</TYPE_OF_ACTIVITY_OTHER></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF VALUE="NO"></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION><OBJECT_CONTRACT_INFORMATION><DESCRIPTION_CONTRACT_INFORMATION><TITLE_CONTRACT><P>BBMR Haemopoietic Stem Cell Services.</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION><TYPE_CONTRACT VALUE="SERVICES"></TYPE_CONTRACT><SERVICE_CATEGORY>25</SERVICE_CATEGORY></TYPE_CONTRACT_LOCATION><LOCATION_NUTS><LOCATION><P>BBMR/NHSBT will manage the referral of it's donors to the prospective service provider.</P></LOCATION></LOCATION_NUTS><NOTICE_INVOLVES VALUE="PUBLIC_CONTRACT"></NOTICE_INVOLVES><SHORT_CONTRACT_DESCRIPTION><P>The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant.</P><P>The requirement is to establish a Hospital based service to independently determine the fitness of volunteer unrelated donors to donate Hematopoietic Stem Cells (HSC) from the Peripheral Blood and, or Lymphocytes as an apheresis procedure and Bone Marrow under general anaesthetic (GA). The Hospital will then admit and collect the product requested from the donor and issue the product.</P><P>The BBMR supports UK and International stem cell transplantation programmes by recruiting volunteer unrelated donors from the blood donor population. They are tissue typed and then available to be searched by accredited Transplant Centres for patients with leukaemia and other blood disorders. The BBMR collects HSC products from donors between the ages of 18 and 60.</P><P>The source of stem cells for first and subsequent donations is from the Bone Marrow under GA, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF). Subsequent donations may also include blood lymphocytes.</P><P>The organisation must be HTA accredited and should be JACIE accredited, or demonstrate progress towards JACIE accreditation. It must demonstrate the resources and capacity to provide a responsive service for the transplant community that the BBMR serves.</P><P>The BBMR is a member of the World Marrow Donor Association, a network of International registries who exchange stem cell products throughout the world. Registration with the Food and Drug Administration (FDA) for HSC products supplied to the USA and Canada is a requirement.</P><P>The policy will commence on 1.10.2011. The projected number of stem cell donations under the contract will be between 150 and 200. The ratio of apheresis procedures to bone marrow is approximately 60:40.</P><P>This contract will be split into two lots, Bone Marrow services and Stem Cell (apheresis) services. Potential suppliers must confirm which lot(s) they will be expressing an interest in (i.e. submitting a bid for at ITT stage, if shortlisted).</P><P>NHSBT reserves the right to split the contract between two providers.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="85121200"></CPV_CODE></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="85100000"></CPV_CODE></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="85141000"></CPV_CODE></CPV_ADDITIONAL></CPV><CONTRACT_COVERED_GPA VALUE="NO"></CONTRACT_COVERED_GPA><F02_DIVISION_INTO_LOTS><F02_DIV_INTO_LOT_YES VALUE="ONE_OR_MORE_LOT"><F02_ANNEX_B><LOT_NUMBER>1</LOT_NUMBER><LOT_TITLE>Bone Marrow Services</LOT_TITLE><LOT_DESCRIPTION><P>The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant.</P><P>The requirement is to establish a Hospital based service to independently determine the fitness of volunteer unrelated donors to donate Hematopoietic Stem Cells (HSC) from the Peripheral Blood and, or Lymphocytes as an apheresis procedure and Bone Marrow under general anaesthetic (GA). The Hospital will then admit and collect the product requested from the donor and issue the product.</P><P>The BBMR supports UK and International stem cell transplantation programmes by recruiting volunteer unrelated donors from the blood donor population. They are tissue typed and then available to be searched by accredited Transplant Centres for patients with leukaemia and other blood disorders. The BBMR collects HSC products from donors between the ages of 18 and 60.</P><P>The source of stem cells for first and subsequent donations is from the Bone Marrow under GA, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF). Subsequent donations may also include blood lymphocytes.</P><P>The organisation must be HTA accredited and should be JACIE accredited, or demonstrate progress towards JACIE accreditation. It must demonstrate the resources and capacity to provide a responsive service for the transplant community that the BBMR serves.</P><P>The BBMR is a member of the World Marrow Donor Association, a network of International registries who exchange stem cell products throughout the world. Registration with the Food and Drug Administration (FDA) for HSC products supplied to the USA and Canada is a requirement.</P><P>The policy will commence on 1.10.2011. The projected number of stem cell donations under the contract will be between 150 and 200. The ratio of apheresis procedures to bone marrow is approximately 60:40.</P><P>This contract will be split into two lots, Bone Marrow services and Stem Cell (apheresis) services. Potential suppliers must confirm which lot(s) they will be expressing an interest in (i.e. submitting a bid for at ITT stage, if shortlisted).</P><P>NHSBT reserves the right to split the contract between two providers.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="85121200"></CPV_CODE></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="85141000"></CPV_CODE></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="85100000"></CPV_CODE></CPV_ADDITIONAL></CPV><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>2</LOT_NUMBER><LOT_TITLE>Stem Cell (apheresis) Services</LOT_TITLE><LOT_DESCRIPTION><P>The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant.</P><P>The requirement is to establish a Hospital based service to independently determine the fitness of volunteer unrelated donors to donate Hematopoietic Stem Cells (HSC) from the Peripheral Blood and, or Lymphocytes as an apheresis procedure and Bone Marrow under general anaesthetic (GA). The Hospital will then admit and collect the product requested from the donor and issue the product.</P><P>The BBMR supports UK and International stem cell transplantation programmes by recruiting volunteer unrelated donors from the blood donor population. They are tissue typed and then available to be searched by accredited Transplant Centres for patients with leukaemia and other blood disorders. The BBMR collects HSC products from donors between the ages of 18 and 60.</P><P>The source of stem cells for first and subsequent donations is from the Bone Marrow under GA, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF). Subsequent donations may also include blood lymphocytes.</P><P>The organisation must be HTA accredited and should be JACIE accredited, or demonstrate progress towards JACIE accreditation. It must demonstrate the resources and capacity to provide a responsive service for the transplant community that the BBMR serves.</P><P>The BBMR is a member of the World Marrow Donor Association, a network of International registries who exchange stem cell products throughout the world. Registration with the Food and Drug Administration (FDA) for HSC products supplied to the USA and Canada is a requirement.</P><P>The policy will commence on 1.10.2011. The projected number of stem cell donations under the contract will be between 150 and 200. The ratio of apheresis procedures to bone marrow is approximately 60:40.</P><P>This contract will be split into two lots, Bone Marrow services and Stem Cell (apheresis) services. Potential suppliers must confirm which lot(s) they will be expressing an interest in (i.e. submitting a bid for at ITT stage, if shortlisted).</P><P>NHSBT reserves the right to split the contract between two providers.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="85121200"></CPV_CODE></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="85141000"></CPV_CODE></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="85100000"></CPV_CODE></CPV_ADDITIONAL></CPV><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B></F02_DIV_INTO_LOT_YES></F02_DIVISION_INTO_LOTS><ACCEPTED_VARIANTS VALUE="NO"></ACCEPTED_VARIANTS></DESCRIPTION_CONTRACT_INFORMATION><PERIOD_WORK_DATE_STARTING><INTERVAL_DATE><START_DATE><DAY>01</DAY><MONTH>10</MONTH><YEAR>2011</YEAR></START_DATE><END_DATE><DAY>30</DAY><MONTH>09</MONTH><YEAR>2012</YEAR></END_DATE></INTERVAL_DATE></PERIOD_WORK_DATE_STARTING></OBJECT_CONTRACT_INFORMATION><LEFTI_CONTRACT><F02_CONDITIONS_FOR_PARTICIPATION><ECONOMIC_OPERATORS_PERSONAL_SITUATION><P>Suppliers instructions how to express interest in this tender:</P><P>1. Register your company on the eSourcing portal (this is only required once):</P><P>— browse to the eSourcing Portal at https://nhsbt.bravosolution.co.uk,</P><P>— click the “Register now!” link,</P><P>— accept the terms and conditions and click “continue”,</P><P>— enter your correct business and user details,</P><P>— note the username you chose and click “Save” when complete,</P><P>— you will shortly receive an email with your unique password (please keep this secure).</P><P>2. Express an Interest in the tender:</P><P>— login to the portal with the username/password,</P><P>— click the “Open Access PQQs” link. (These are Pre-Qualification Questionnaires open to any registered supplier),</P><P>— click on the relevant PQQ to access the content,</P><P>— click the “Express Interest” button in the “Actions” box on the left-hand side of the page,</P><P>— this will move the PQQ into your “My PQQs” page. (This is a secure area reserved for your projects only),</P><P>— click on the PQQ code, you can now access any attachments by clicking the “Settings and Buyer Attachments” in the “Actions” box.</P><P>3. Responding to the tender:</P><P>— you can now choose to “Reply” or “Reject” (please give a reason if rejecting),</P><P>— you can now use the ‘Messages’ function to communicate with the buyer and seek any clarification,</P><P>— note the deadline for completion, then follow the onscreen instructions to complete the PQQ,</P><P>— there may be a mixture of online &amp; offline actions for you to perform (there is detailed online help available).</P><P>If you require any further assistance please consult the online help, or contact the eTendering help desk.</P></ECONOMIC_OPERATORS_PERSONAL_SITUATION><F02_ECONOMIC_FINANCIAL_CAPACITY><EAF_CAPACITY_INFORMATION><P>Suppliers should endeavour to submit in as complete a form as possible as will be used as part of the evaluation process. Items (i) and (ii) are regarded as very.</P><P>Important:</P><P>i) appropriate statements from bankers (if annual reports are not required to be submitted - this is applicable to companies which are not registered);</P><P>ii) submission of last 3 years annual reports and balance sheet;</P><P>iii) statement of overall turnover in respect of the goods / services to be covered by the contract for the 3 previous financial years;</P><P>iv) the company registration number and registered office address (if applicable);</P><P>v) details of your organisation's insurance protection in respect of employers, public/product and professional indemnity and provide a copy of any certificates.</P></EAF_CAPACITY_INFORMATION></F02_ECONOMIC_FINANCIAL_CAPACITY><TECHNICAL_CAPACITY_LEFTI><T_CAPACITY_INFORMATION><P>i) a list of major contracts won, and their value, in the last 3 years;</P><P>ii) provide details of contracts of a similar nature and their value;</P><P>iii) a description of the supplier's technical facilities and measures for ensuring quality control, including reference to any independent certificated audit standard achieved providing copies of those certificates where appropriate;</P><P>iv) if necessary a check may be made by the contracting Authority, or a competent official body in the supplier's country of origin acting on their behalf on production capacities and quality control measures.</P></T_CAPACITY_INFORMATION></TECHNICAL_CAPACITY_LEFTI><NO_RESERVED_CONTRACTS></NO_RESERVED_CONTRACTS></F02_CONDITIONS_FOR_PARTICIPATION></LEFTI_CONTRACT><PROCEDURE_DEFINITION_CONTRACT_NOTICE><TYPE_OF_PROCEDURE><TYPE_OF_PROCEDURE_DETAIL_FOR_CONTRACT_NOTICE><PT_RESTRICTED></PT_RESTRICTED></TYPE_OF_PROCEDURE_DETAIL_FOR_CONTRACT_NOTICE><MAXIMUM_NUMBER_INVITED><OPE_MINIMUM_NUMBER>5</OPE_MINIMUM_NUMBER><OPE_MAXIMUM_NUMBER>20</OPE_MAXIMUM_NUMBER></MAXIMUM_NUMBER_INVITED></TYPE_OF_PROCEDURE><AWARD_CRITERIA_CONTRACT_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL><MOST_ECONOMICALLY_ADVANTAGEOUS_TENDER><CRITERIA_STATED_BELOW><CRITERIA_DEFINITION><ORDER_C>1</ORDER_C><CRITERIA>Technical</CRITERIA><WEIGHTING>280</WEIGHTING></CRITERIA_DEFINITION><CRITERIA_DEFINITION><ORDER_C>2</ORDER_C><CRITERIA>Quality</CRITERIA><WEIGHTING>150</WEIGHTING></CRITERIA_DEFINITION><CRITERIA_DEFINITION><ORDER_C>3</ORDER_C><CRITERIA>Delivery performance</CRITERIA><WEIGHTING>70</WEIGHTING></CRITERIA_DEFINITION><CRITERIA_DEFINITION><ORDER_C>4</ORDER_C><CRITERIA>General</CRITERIA><WEIGHTING>150</WEIGHTING></CRITERIA_DEFINITION><CRITERIA_DEFINITION><ORDER_C>5</ORDER_C><CRITERIA>Cost</CRITERIA><WEIGHTING>350</WEIGHTING></CRITERIA_DEFINITION></CRITERIA_STATED_BELOW></MOST_ECONOMICALLY_ADVANTAGEOUS_TENDER></AWARD_CRITERIA_DETAIL><IS_ELECTRONIC_AUCTION_USABLE><NO_USE_ELECTRONIC_AUCTION></NO_USE_ELECTRONIC_AUCTION></IS_ELECTRONIC_AUCTION_USABLE></AWARD_CRITERIA_CONTRACT_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_NOTICE><FILE_REFERENCE_NUMBER><P>NHSBT0020/S/SP</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F2><NO_PREVIOUS_PUBLICATION_EXISTS_F2></NO_PREVIOUS_PUBLICATION_EXISTS_F2></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F2><RECEIPT_LIMIT_DATE><DAY>28</DAY><MONTH>02</MONTH><YEAR>2011</YEAR><TIME>12:00</TIME></RECEIPT_LIMIT_DATE><DISPATCH_INVITATIONS_DATE><DAY>31</DAY><MONTH>03</MONTH><YEAR>2011</YEAR></DISPATCH_INVITATIONS_DATE><LANGUAGE><LANGUAGE_EC VALUE="EN"></LANGUAGE_EC></LANGUAGE></ADMINISTRATIVE_INFORMATION_CONTRACT_NOTICE></PROCEDURE_DEFINITION_CONTRACT_NOTICE><COMPLEMENTARY_INFORMATION_CONTRACT_NOTICE><NO_RECURRENT_PROCUREMENT></NO_RECURRENT_PROCUREMENT><RELATES_TO_EU_PROJECT_NO></RELATES_TO_EU_PROJECT_NO><ADDITIONAL_INFORMATION><P>The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.</P><P>The Contracting Authority will not shortlist any supplier to be invited to tender where any of the reasons detailed in Section 23 of UK Statutory Instrument 2006 No 5, The Public Contracts Regulations 2006, are deemed to apply.</P><P>Where an economic operator is unable for a valid reason to provide the financial information which the Contracting Authority has requested in III, III.2.2, and III.2.3 above, the Contracting Authority shall accept such other information provided by the economic operator as the Contracting Authority considers appropriate.</P><P>The Contracting Authority will shortlist suppliers to be invited to tender based upon an assessment of the information provided in response to III, III.2.2 and III.2.3 above.</P><P>The Contracting Authority may require potential suppliers to complete a Pre-Qualification Questionnaire (PQQ) and in such event the potential suppliers must complete the PQQ using the NHSBT e-Sourcing portal. This process and information provided will be used to enable the Contracting Authority to shortlist suppliers to be invited to tender in addition to that information already referred to above.</P><P>The Selection Criteria for shortlisting suppliers to be invited to tender will be economic and financial standing and technical and professional ability.</P><P>Shortlisted suppliers may be invited to attend a pre-tender meeting.</P><P>Award criteria.</P><P>The detailed award criteria and weightings will be stated in the invitation to tender, together with any sub-criteria if appropriate.</P><P>General.</P><P>The Authority reserves the right to award all, part or none of the business.</P><P>The Authority may extend this contract by a further six, one-year periods.</P></ADDITIONAL_INFORMATION><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION>As the UK does not have any such body with responsibility for appeals procedures please refer to section VI.4.2 below.</ORGANISATION></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE><LODGING_OF_APPEALS><LODGING_OF_APPEALS_PRECISION><P>This authority (NHSBT – NHS Blood and Transplant) will incorporate a minimum 10 calendar day standstill period at the point information on the award of the contract is communicated to tenderers. This period allows unsuccessful tenderers to seek further debriefing from the contracting authority before the contract is entered into. Applicants have 2 working days from the notification of the award decision to request additional debriefing and that information has to be provided a minimum of 3 working days before the expiry of the standstill period. Such additional information should be requested from Mrs Shirley Phillips, National Purchasing Manager Estates and Services, NHS Blood and Transplant, North Bristol Park, Park Way, Filton, Bristol, BS34 7QH.</P><P>If an appeal regarding the award of a contract has not been successfully resolved the Public Contracts Regulations 2006 (SI 2006 No 5) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England). Any such action must be brought promptly (generally within 3 months). Where a contract has not been entered into the Court may order the setting aside of the award decision or order the authority to amend any document and may award damages. If the contract has been entered into the Court may only award damages.</P></LODGING_OF_APPEALS_PRECISION></LODGING_OF_APPEALS></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>20</DAY><MONTH>01</MONTH><YEAR>2011</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_NOTICE></FD_CONTRACT></CONTRACT></FORM_SECTION></TED_EXPORT>